Search

Bruce F Bell

Examiner (ID: 11075)

Most Active Art Unit
1741
Art Unit(s)
1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102
Total Applications
2788
Issued Applications
2338
Pending Applications
153
Abandoned Applications
297

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16525184 [patent_doc_number] => 20200399264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 16/902080 [patent_app_country] => US [patent_app_date] => 2020-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 509 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902080 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/902080
4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS Jun 14, 2020 Abandoned
Array ( [id] => 16343461 [patent_doc_number] => 20200308111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => Cationic Lipid [patent_app_type] => utility [patent_app_number] => 16/897752 [patent_app_country] => US [patent_app_date] => 2020-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18715 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897752 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/897752
Cationic lipid Jun 9, 2020 Issued
Array ( [id] => 16483918 [patent_doc_number] => 20200377519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => HEPATITIS B ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 16/891401 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/891401
Hepatitis B antiviral agents Jun 2, 2020 Issued
Array ( [id] => 16885275 [patent_doc_number] => 20210171470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR [patent_app_type] => utility [patent_app_number] => 16/888484 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888484 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/888484
Compounds and methods for the targeted degradation of androgen receptor May 28, 2020 Issued
Array ( [id] => 16468157 [patent_doc_number] => 20200369694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES [patent_app_type] => utility [patent_app_number] => 15/930756 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930756 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/930756
NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES May 12, 2020 Abandoned
Array ( [id] => 16696633 [patent_doc_number] => 10947213 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-16 [patent_title] => TLR7/8 antagonists and uses thereof [patent_app_type] => utility [patent_app_number] => 15/929348 [patent_app_country] => US [patent_app_date] => 2020-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95014 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15929348 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/929348
TLR7/8 antagonists and uses thereof Apr 27, 2020 Issued
Array ( [id] => 16570568 [patent_doc_number] => 20210009574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => Amine derivative and an organic electroluminescent device thereof [patent_app_type] => utility [patent_app_number] => 16/848401 [patent_app_country] => US [patent_app_date] => 2020-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11582 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/848401
Amine derivative and an organic electroluminescent device thereof Apr 13, 2020 Issued
Array ( [id] => 16290053 [patent_doc_number] => 10766888 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-09-08 [patent_title] => HMOX1 inducers [patent_app_type] => utility [patent_app_number] => 16/843426 [patent_app_country] => US [patent_app_date] => 2020-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 56271 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843426 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/843426
HMOX1 inducers Apr 7, 2020 Issued
Array ( [id] => 18153039 [patent_doc_number] => 11565999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Methods of synthesizing aztreonam derivatives [patent_app_type] => utility [patent_app_number] => 16/840675 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28977 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840675 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/840675
Methods of synthesizing aztreonam derivatives Apr 5, 2020 Issued
Array ( [id] => 18389949 [patent_doc_number] => 20230158167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => SITE-SPECIFIC ANTIBODY CONJUGATION AND ANTIBODY-DRUG CONJUGATE AS SPECIFIC EMBODIMENT THEREOF [patent_app_type] => utility [patent_app_number] => 16/980503 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980503 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980503
SITE-SPECIFIC ANTIBODY CONJUGATION AND ANTIBODY-DRUG CONJUGATE AS SPECIFIC EMBODIMENT THEREOF Mar 8, 2020 Pending
Array ( [id] => 16360870 [patent_doc_number] => 20200317621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/813230 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813230 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813230
POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF Mar 8, 2020 Abandoned
Array ( [id] => 16756542 [patent_doc_number] => 10975078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Fused indazole pyridone compounds as antivirals [patent_app_type] => utility [patent_app_number] => 16/808985 [patent_app_country] => US [patent_app_date] => 2020-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42025 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/808985
Fused indazole pyridone compounds as antivirals Mar 3, 2020 Issued
Array ( [id] => 16792902 [patent_doc_number] => 20210122719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => Method For Preparing Aryl 2-Tetrazol-1-Yl Keto With Improved Selectivity [patent_app_type] => utility [patent_app_number] => 16/803039 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4776 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803039 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/803039
Method for preparing aryl 2-tetrazol-1-yl keto with improved selectivity Feb 26, 2020 Issued
Array ( [id] => 16297726 [patent_doc_number] => 20200283449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => SOLID FORMS OF AN ANTIVIRAL COMPOUND [patent_app_type] => utility [patent_app_number] => 16/797793 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797793 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/797793
Solid forms of an antiviral compound Feb 20, 2020 Issued
Array ( [id] => 17490422 [patent_doc_number] => 11279711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases [patent_app_type] => utility [patent_app_number] => 16/795884 [patent_app_country] => US [patent_app_date] => 2020-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 595 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795884 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/795884
Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases Feb 19, 2020 Issued
Array ( [id] => 17513665 [patent_doc_number] => 11292794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => 3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same [patent_app_type] => utility [patent_app_number] => 16/791715 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 81 [patent_no_of_words] => 82602 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/791715
3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same Feb 13, 2020 Issued
Array ( [id] => 17014084 [patent_doc_number] => 11083703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-10 [patent_title] => Prodrugs of fumarates and their use in treating various diseases [patent_app_type] => utility [patent_app_number] => 16/790849 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20769 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790849
Prodrugs of fumarates and their use in treating various diseases Feb 13, 2020 Issued
Array ( [id] => 16549683 [patent_doc_number] => 10882832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Bicyclic heteroaryl derivatives and preparation and uses thereof [patent_app_type] => utility [patent_app_number] => 16/791243 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 25436 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791243 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/791243
Bicyclic heteroaryl derivatives and preparation and uses thereof Feb 13, 2020 Issued
Array ( [id] => 16012627 [patent_doc_number] => 20200181156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => CARBOXY TETRAHYDROPYRAZOLOPYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES [patent_app_type] => utility [patent_app_number] => 16/790400 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790400 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/790400
CARBOXY TETRAHYDROPYRAZOLOPYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES Feb 12, 2020 Abandoned
Array ( [id] => 16977557 [patent_doc_number] => 20210221794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => ISATIN DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/747297 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747297 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/747297
ISATIN DERIVATIVES Jan 19, 2020 Abandoned
Menu